Asep Medical Holdings Inc. (SEPSF)
Asep Medical Holdings Inc., operating primarily through its subsidiary ASEP Medical Inc., is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions. The company, initially incorporated in 2020 under the name Trenchant Life Sciences Investment Corp., later rebranded to its present title, Asep Medical Holdings Inc. Its corporate base of operations is located in Vancouver, Canada.
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Biotechnology
Asep Medical Holdings Inc
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 10.86M shares outstanding
No company description available.
Leadership
Fadia Saad
Chief Business Development Officer
Jacqueline Tucker FCPA
Chief Financial Officer
Evan Haney
Chief Scientific Officer
Richard Heinzl
Interim CEO & Chairman of the Board
Employees
--
Country
--
Sector
Healthcare
Website
--
based on 10.86M shares outstanding
30d Avg
--
60d Avg
--
90d Avg
--